Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 02, 2022

SELL
$28.19 - $46.6 $2,396 - $3,961
-85 Closed
0 $0
Q4 2021

Feb 02, 2022

SELL
$41.2 - $73.6 $2,060 - $3,679
-50 Reduced 37.04%
85 $4,000
Q2 2021

Aug 04, 2021

SELL
$63.02 - $95.11 $688,115 - $1.04 Million
-10,919 Reduced 98.78%
135 $12,000
Q1 2021

May 04, 2021

BUY
$57.62 - $95.6 $395,273 - $655,816
6,860 Added 163.57%
11,054 $753,000
Q4 2020

Feb 08, 2021

BUY
$41.43 - $77.09 $173,757 - $323,315
4,194 New
4,194 $304,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Migdal Insurance & Financial Holdings Ltd. Portfolio

Follow Migdal Insurance & Financial Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.